SCHEMBL4606264

SCHEMBL4606264

C#CCOc1nsc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45
MAOB P27338 11/20 0.44
MAOA P21397 5/20 0.44
MAPK1 P28482 2/20 0.44
POLB P06746 1/20 0.44
HSD17B10 Q99714 1/20 0.44
P2RY1 P47900 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605578 0.82 ADORA3 (0.42) ADORA3ADORA2AADORA2BADORA1MAPK1
SCHEMBL29600941 0.73 ADORA3 (0.53) ADORA3ADORA2AADORA2BADORA1MAPK1
SCHEMBL6581398 0.72 TDP1 (0.49) ADORA3ADORA2AADORA2BADORA1ALDH1A1
SCHEMBL14207832 0.70 ALDH1A1 (0.56) MAOBMAOAPOLBALDH1A1
SCHEMBL17198727 0.69 POLB (0.54) MAOBMAOAMAPK1POLBHSD17B10
SCHEMBL10933434 0.66 SMN1; SMN2 (0.46) ADORA3ADORA2AADORA1MAOBMAOA
SCHEMBL10932402 0.66 MAOB (0.42) MAOBMAOAMAPK1POLBHSD17B10
SCHEMBL536433 0.65 MAOB (0.68) MAOBMAOACYP1A1CYP1A2CYP1B1
SCHEMBL690812 0.64 MAPK1 (1.00) MAOBMAOAMAPK1POLBHSD17B10
SCHEMBL2212694 0.64 CYP19A1 (0.67) ADORA3ADORA2AADORA2BADORA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 ADORA3 497/4885ADORA2A 2646/4885ADORA2B 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.